000 01137 a2200325 4500
005 20250517171740.0
264 0 _c20171016
008 201710s 0 0 eng d
022 _a1600-0447
024 7 _a10.1111/acps.12795
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEbdrup, B H
245 0 0 _a'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' response.
_h[electronic resource]
260 _bActa psychiatrica Scandinavica
_c11 2017
300 _a526-527 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAntipsychotic Agents
650 0 4 _aGlucagon-Like Peptide-1 Receptor
650 0 4 _aHumans
650 0 4 _aObesity
650 0 4 _aSchizophrenia
700 1 _aIshøy, P L
700 1 _aFagerlund, B
700 1 _aBroberg, B V
700 1 _aBak, N
700 1 _aKnop, F K
700 1 _aGlenthøj, B Y
773 0 _tActa psychiatrica Scandinavica
_gvol. 136
_gno. 5
_gp. 526-527
856 4 0 _uhttps://doi.org/10.1111/acps.12795
_zAvailable from publisher's website
999 _c27503435
_d27503435